XL-protein GmbH

General information
XL-protein GmbH
Lise-Meitner-Str. 30
85354 Freising, Bavaria
Germany

Contact person: Claus Schalper, Managing Director
Company main phone: +49 (8161) 5373090
Company main fax:  +49 (8161) 5373099
Website:  www.xl-protein.com
Year founded:2009
Source of foundation:Spin-off from university
Name of foundation source:Insitute of Biological Chemistry at the Technische Universit√§t M√ľnchen (TUM)
Corporate description / mission:
XL-protein GmbH is a privatly owned German biotech company commercializing the revolutionary 'PASylation' technology, which allows the extension of the plasma half-life of biopharmaceuticals. The company will focus on the preclinical as well clinical development of PASylated proteins in several disease areas.
State of ownership: Private / independent
Headquarters: Yes
Categorization
Sector:
  • Biotechnology - Therapeutics and Diagnostics
Subsector:
  • Proteins
Primary therapeutic areas:
  • Diseases of the blood and blood-forming organs & immune disorders / hematology / immunology
  • Diseases of the eye / ophthalmology
  • Diseases of the nervous system / neurology
  • Endocrine, nutritional and metabolic diseases / endocrinology
  • Infectious and parasitic diseases / infectiology / parasitology
  • Injury, poisoning and certain other consequences of external causes / toxicology
  • Musculoskeletal system and connective tissue / Orthopedics
  • Neoplasms / cancer / oncology
Business model:
  • In-licensing
  • Out-licensing
  • R&D
Customer segments:
  • Hospitals
  • Large biotech & big pharma
  • Small biotech
Summary Products / Services / Technologies
Technology used:
PAS-Technology
X